2022 HF Guidelines: Highlighting the Continuum of Care

                                                         **3.00 Total Contact Hours

Register and View Agenda

All times are listed in Eastern Time.

The purpose of this program is to review the important changes to the 2022 AHA/ACC/HFSA guidelines for the management of heart failure. The program will include a discussion on the latest pharmacological and device therapies for heart failure, with multidisciplinary experts in the field of HF.  Strategies to incorporate guideline-directed medical therapies (GDMT) into clinical practice will also be highlighted in this program. The intended audience for this program is physicians, nurses, advanced practice providers, pharmacists, and SWS. 

Contact Hours -  Earn 3.00 CEs and Pharm Credit**

Attendees may earn contact hours by attending the meeting and completing the evaluation.

ANCC Accreditation Statement

This activity is provided by the American Association of Heart Failure Nurses (AAHFN). The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

AANP Accreditation Statement: 

This activity is provided by the American Association of Heart Failure Nurses (AAHFN). This activity is approved for 3.0 contact hour(s) of continuing education (which includes 3.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners. Activity ID# 22115893. This activity was planned in accordance with AANP Accreditation Standards

Registration Fees

Disclaimer

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Questions?

Contact: Emma Pestritto at epestritto@aahfn.org.

*Content, Dates, and Times are subject to change
**This number is an estimate until final approval is provided by the accrediting organization